Mostafa M. Elshafey

547 total citations
14 papers, 450 citations indexed

About

Mostafa M. Elshafey is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mostafa M. Elshafey has authored 14 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Mostafa M. Elshafey's work include MicroRNA in disease regulation (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Mostafa M. Elshafey is often cited by papers focused on MicroRNA in disease regulation (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Mostafa M. Elshafey collaborates with scholars based in Egypt and Saudi Arabia. Mostafa M. Elshafey's co-authors include Ahmed S. Doghish, Samir A. Salama, Hamdy A.A. Aly, Hesham A. El-Beshbishy, Ahmed Elshafei, Ahmed M. Mohamadin, Mohamed A. Elkady, Gamil M. Abd‐Allah, Tamer M. Abdelghany and Amr D. Mariee and has published in prestigious journals such as Gene, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Mostafa M. Elshafey

14 papers receiving 446 citations

Peers

Mostafa M. Elshafey
Hua Yao China
Yuhun Lu United States
Quan Shi China
Ying Piao China
Hua Yao China
Mostafa M. Elshafey
Citations per year, relative to Mostafa M. Elshafey Mostafa M. Elshafey (= 1×) peers Hua Yao

Countries citing papers authored by Mostafa M. Elshafey

Since Specialization
Citations

This map shows the geographic impact of Mostafa M. Elshafey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mostafa M. Elshafey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mostafa M. Elshafey more than expected).

Fields of papers citing papers by Mostafa M. Elshafey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mostafa M. Elshafey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mostafa M. Elshafey. The network helps show where Mostafa M. Elshafey may publish in the future.

Co-authorship network of co-authors of Mostafa M. Elshafey

This figure shows the co-authorship network connecting the top 25 collaborators of Mostafa M. Elshafey. A scholar is included among the top collaborators of Mostafa M. Elshafey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mostafa M. Elshafey. Mostafa M. Elshafey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Elrebehy, Mahmoud A., et al.. (2023). miR-509–5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11. Pathology - Research and Practice. 247. 154557–154557. 48 indexed citations
2.
Elshafei, Ahmed, et al.. (2023). Identification of miR-106b-5p, miR-601, and miR-760 Expression and Their Clinical Values in Non-Small Cell Lung Cancer (NSCLC) Patients' Serum. Pathology - Research and Practice. 248. 154663–154663. 6 indexed citations
3.
Salama, Samir A. & Mostafa M. Elshafey. (2022). Cross-talk between PPARγ, NF-κB, and p38 MAPK signaling mediates the ameliorating effects of bergenin against the iron overload-induced hepatotoxicity. Chemico-Biological Interactions. 368. 110207–110207. 15 indexed citations
5.
Elkady, Mohamed A., Ahmed S. Doghish, Ahmed Elshafei, & Mostafa M. Elshafey. (2021). MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8. Saudi Journal of Biological Sciences. 28(4). 2581–2590. 77 indexed citations
6.
Salama, Samir A. & Mostafa M. Elshafey. (2021). Galangin mitigates iron overload-triggered liver injury: Up-regulation of PPARγ and Nrf2 signaling, and abrogation of the inflammatory responses. Life Sciences. 283. 119856–119856. 28 indexed citations
7.
Hegazy, Maghawry, et al.. (2020). Pioglitazone ameliorates high fat diet-induced hypertension and induces catechol o-methyl transferase expression in rats. European Journal of Pharmacology. 885. 173383–173383. 4 indexed citations
8.
Doghish, Ahmed S., Ahmed I. Abulsoud, Mohamed G. Ewees, et al.. (2020). Effect of scopoletin on phagocytic activity of U937-derived human macrophages: Insights from transcriptomic analysis. Genomics. 112(5). 3518–3524. 47 indexed citations
10.
Abo‐Elfadl, Mahmoud T., et al.. (2016). Photothermal therapeutic effect of PEGylated gold nano-semicubes in chemically-induced skin cancer in mice. Journal of Photochemistry and Photobiology B Biology. 164. 21–29. 22 indexed citations
11.
Elkhawaga, Samy Y., et al.. (2016). Clinical significance of TNFAIP3 rs2230926 T > G gene polymorphism in Egyptian cases with rheumatoid arthritis. Meta Gene. 11. 58–63. 4 indexed citations
12.
Elshafey, Mostafa M., et al.. (2016). Clinical Signifiance of Follistatin in Obese and Non-obese Egyptian Polycystic Ovarian Patients. 5(1). 10–10. 2 indexed citations
13.
Elshafey, Mostafa M., Gamil M. Abd‐Allah, Ahmed M. Mohamadin, Gamaleldin I. Harisa, & Amr D. Mariee. (2014). Quercetin protects against acetaminophen-induced hepatorenal toxicity by reducing reactive oxygen and nitrogen species. Pathophysiology. 22(1). 49–55. 54 indexed citations
14.
El-Beshbishy, Hesham A., Hamdy A.A. Aly, & Mostafa M. Elshafey. (2012). Lipoic acid mitigates bisphenol A-induced testicular mitochondrial toxicity in rats. Toxicology and Industrial Health. 29(10). 875–887. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026